Xconomy National

Archives

by in

Entry	Author	Date	Location
CircuLite Attracts Big Support for Tiny Heart-Assist Device	Arlene Weintraub	01/05/12	New York
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers	Luke Timmerman	09/22/11	San Diego
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public	Ryan McBride	04/21/11	Boston
HeartWare Gets $143.8M in Debt Offering	Ryan McBride	12/15/10	Boston
BG Medicine Wins FDA OK, Primes Pump for Second Shot at IPO	Luke Timmerman	11/24/10	Boston
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News	Bruce V. Bigelow	06/03/10	San Diego
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study	Luke Timmerman	06/01/10	San Diego
NormOxys Pockets $17.5M for Drugs Against Heart Failure, Cancer	Luke Timmerman	05/24/10	Boston
Cytori Heartened by Cell Therapy in Two Small Studies of Cardiac Patients	Denise Gellene	05/07/10	San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details	Luke Timmerman	04/28/10	San Diego
QuantumCor Sees Future of Heart Failure Treatment in No Device Left Behind	Luke Timmerman	11/02/09	Seattle
Celladon CEO Upbeat on Gene Therapy for Heart	Denise Gellene	05/29/09	San Diego
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown	Luke Timmerman	05/07/09	Seattle
Targeted Genetics Hands Off Manufacturing	Luke Timmerman	03/02/09	Seattle
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News	Luke Timmerman	02/05/09	Seattle
Cardiac Dimensions Wins European Clearance to Sell Device for Heart Failure	Luke Timmerman	01/29/09	Seattle
Seattle Genetics Raises Dough, Trubion Feels Fallout of Pfizer Deal, Novo Sets Up Shop, & More Seattle-Area Life Sciences News	Luke Timmerman	01/29/09	Seattle
NitroMed Takes Buyout Offer from Deerfield, Dumps Archemix at the Altar	Ryan McBride	01/27/09	Boston
Cardiac Dimensions, Fixer of Leaky Hearts, Edges Toward European Market and Pivotal U.S. Test	Luke Timmerman	01/26/09	Seattle
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure	Luke Timmerman	11/30/08	San Diego
Abiomed To Sell 2.4 Million Shares of Common Stock	Luke Timmerman	08/19/08	Boston
Page 1 of 1